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Abstract
The leucine aminopeptidase from Aeromonas proteolytica (also known as Vibrio proteolyticus) (AAP) is a
metalloenzyme with broad substrate specificity. The open reading frame (ORF) for AAP encodes a 54 kDa
enzyme, however, the extracellular enzyme has a molecular weight of 43 kDa. This form of AAP is further
processed to a mature, thermostable 32 kDa form but the exact nature of this process is unknown. Overexpression of different forms of AAP in Escherichia coli (with AAP's native leader sequence, with and without the
N- and/or C-terminal propeptides, and as fusion protein) has allowed a model for the processing of wild-type
AAP to be proposed. The role of the A. proteolytica signal peptide in protein secretion as well as comparison to
other known signal peptides reveals a close resemblance of the A. proteolytica signal peptide to the outer
membrane protein (OmpA) signal peptide. Over-expression of the full 54 kDa AAP enzyme provides an enzyme
that is significantly less active, due to a cooperative inhibitory interaction between both propeptides. Overexpression of AAP lacking its C-terminal propeptide provided an enzyme with an identical kcat value to wild-type
AAP but exhibited a larger Km value, suggesting competitive inhibition of AAP by the N-terminal propeptide
(Ki∼0.13 nM). The recombinant 32 kDa form of AAP was characterized by kinetic and spectroscopic methods and
was shown to be identical to mature, wild-type AAP. Therefore, the ease of purification and processing of rAAP
along with the fact that large quantities can be obtained now allow new detailed mechanistic studies to be
performed on AAP through site-directed mutagenesis.
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Introduction
Enzymes containing dinuclear metallo-active sites are central to numerous biological processes and,
consequently, characterization of their structure and function is a problem of outstanding importance [1]. These
enzymes play key roles in carcinogenesis, tissue repair, and protein degradation processes. In addition, some of
the enzymes within this group catalyze the hydrolysis of phosphorus(V) compounds found in nerve gases and
agricultural neurotoxins [1]. One of these, the leucine aminopeptidase from Aeromonas proteolytica (Vibrio
proteolyticus) (AAP; EC 3.4.11.10)1 is capable of removing nearly any hydrophobic N-terminal amino acid residue
from a polypeptide chain [1]. Leucine aminopeptidases are widely distributed in nature and play important roles
in many biological processes including protein catabolism, degradation of hormones, wound response in plants,
polypeptide trimming prior to their presentation to MHC-I, regulation of migration and cell proliferation, as well
as HIV infection and proliferation [2], [3], [4], [5], [6], [7], [8], [9]. Therefore, the determination of a detailed
reaction mechanism for leucine aminopeptidases is a required pre-requisite for the design of highly potent,
specific inhibitors that can function as potential pharmaceuticals.
The as-purified AAP enzyme is small (32 kDa), monomeric, and is fully activated by two equivalents of Zn(II).
However, the open reading frame (ORF) of AAP encodes a 54,223 Da protein that consists of four domains—a
signal peptide (21 amino acids), an N-terminal propeptide (85 amino acids), the mature protein (291 residues),
and a C-terminal propeptide (107 amino acids) [10], [11]. Upon expression of AAP in A. proteolytica (V.
proteolyticus), three major bands are present on SDS–PAGE with approximate molecular weights of 50, 44, and
32 kDa. The first band likely corresponds to the molecular weight of the full-length protein without its signal
peptide, while the second lacks either part or all of the N- or C-terminal propeptide. The third band corresponds
to the mature, wild-type enzyme. The higher molecular weight enzymes are thermally unstable and undergo
processing at 70 °C to form a heat-stable 32 kDa protein; however, the nature of this process remains unknown
[12]. AAP is partially digested by an unknown processing enzyme of which a potential candidate is a Zn(II)dependent neutral protease co-expressed with AAP [13], [14]. Alternatively, AAP may undergo auto-processing,
which would make it the only known co-catalytic metalloendopeptidase to undergo such a process.

The N-terminal propeptide of AAP has been shown to be an absolute requirement for proper folding of the
enzyme [15]. In addition, this propeptide has been shown to display some inhibitory properties based on the
observed increase in the Km value towards l-leucine-p-nitroanilide (l-pNA) [16]. On the other hand, the role of
the C-terminal propeptide remains unknown. It has been shown that the C-terminal propeptide exhibits high
sequence identity (52.6%) and homology (63.9%) with 100 terminal amino acids of Vibrio cholerae
hemagglutinin/proteinase and 47.9% identity and 59% homology with the last 100 amino acids of Vibrio
alginolyticus serine exoproteinase A [10]. However, very little is known about the function of the C-termini of
these enzymes, although similar to AAP, a truncation at the C-terminus of hemagglutinin/proteinase of V.
cholerae resulted in an increase in the observed catalytic activity [17].
Herein, we report the over-expression of AAP in Escherichia coli in several different forms (i.e., with and without
the native signal sequence, with and without the C-terminal propeptide, and as a fusion protein). The effect of
the native signal peptide on the extracellular secretion of AAP from E. coli was evaluated and compared to those
of other E. coli leader sequences. The inhibitory properties of the N- and C-terminal propeptides on the
hydrolysis of l-pNA by AAP were also examined and, based on kinetic data, a role for the C-terminal propeptide
is proposed. Combination of these data has allowed a model for AAP processing to be proposed. Finally, the
kinetic and spectroscopic properties of the recombinant, 32 kDa form of AAP were examined and compared to
those of mature AAP.

Materials and methods
All chemicals used were purchased from Sigma and Fisher and were of the highest quality available. All
biochemicals were purchased from Promega unless stated otherwise. All DNA and bacterial manipulations were
performed under sterile conditions in a Laminar Flow unit (Agnew Higgins, Garden Grove, CA).

Comparison of the signal peptide of AAP to other signal peptides
Analysis of the propeptide sequence was performed using a web-based service operated by the Swiss Institute
of Bioinformatics, using program ProtScale (http://us.expasy.org/cgi-bin/protscale.pl). This service uses the
method developed by Kyte and Doolittle [18] with a window size of seven amino acids. The figures were
generated using IgorPro (Wavematrix, Lake Oswego, OR). The AAP sequence accession number in the EMBL
Data Library is Z11993 [10]. Comparison to other signal peptides such as PelB, MalE, and OmpA was performed
using identical parameters [19].

Preparation of the AAP gene for cloning
The vep-pap vector containing DNA encoding the ORF (54 kDa protein) was kindly provided by Fred A. Wagner of
the University of Nebraska. The plasmid was purified from E. coli JM109 cells (recA1 endA1 gyrA96 thi hsdR17
(rK−, mK+) relA1 supE44 Δ(lac-proAB) [F′ traD36 proAB lacIqZΔM15]) using Promega's Wizard Plus Minipreps DNA
Purification System (Promega, Madison, WI) according to the manufacturer's instructions. The plasmid (100 μg)
was incubated with 5 μl HindIII (10 U/μl) (Promega, Madison, WI) for 2 h at 37 °C. The digest was then isolated
from the agarose gel (0.8%) using the Geneclean II Kit (Bio 101, Vista, CA). The plasmid was stored in doubly
distilled, sterile water at −20 °C.
PCRs were performed on the vep-pap digest using the following primers (restriction enzymes recognition sites
are underlined): (1) for the pT7 vector: 54 kDa form: 5′-CTA GCATATGAA ATA TAC CAA AAC G-3′ and 5′-CTA
GAAGCTTAG TGA CGT ATG TCA G-3′, (NdeI and HindIII); (2) for the pMAL-c2X vector: 5′-AGAATTCAT GCC GCC
GAT TAC ACA G-3′ and 5′-CTAAGCTTC AGC CTG GTG TTG GTG T-3′, (EcoRI and HindIII); and (3) for the pET27b(+):
(i) for the 43 kDa AAP (ΔC-AAP): 5′-CTCCATGGA TAT GAA ATA TAC CAAA-3′ and 5′-CTAAGCTTC AGC CTG GTG TTG
GTGT-3′, (NcoI and HindIII); (ii) for the 32 kDa form of AAP: 5′-AGA TAT GCC GCC GAT TACA-3′ and 5′-CTCCATGGC
AGC CTG GTG TTG GTG T-3′, (NcoI and HindIII). All oligomers were obtained from Operon Technologies,

Alameda, CA. PCR was carried out with Ready-To-Go PCR Beads (Amersham–Pharmacia Biotech, Piscataway, NJ)
with the following cycling parameters: stage 1 (94 °C × 5 min) × 1; stage 2 (94 °C × 5 min, 55 °C × 30 s, and
72 °C × 30 s) × 25; and stage 3 (72 °C × 7 min) × 1; then cooled to 4 °C. The PCR product was then isolated from
an 0.8% agarose gel.

Cloning of the AAP gene
Each of the isolated PCR products was ligated into pGEM-T Easy or pGEM-T vectors (AAP DNA containing EcoRI
restriction enzyme site) (Promega, Madison, WI) and transformed into DH5α competent cells [F−
φ80dlacZΔM15Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK−, mK+) phoA supE44 λ− thi-1 gyrA96 relA1]
(Invitrogen, Carlsbad, CA). Each of the plasmids was subsequently isolated from the bacterial host as previously
described. Each pGEM-AAP vector was subjected to digestion with their respective restriction enzymes
(Promega, WI; Invitrogen, Carlsbad, CA; Fermentas, Vilnius, Lithuania) and the digests encoding AAP were
isolated from an agarose gel. The pT7 vector (a gift from Dr. John W. Peters, Utah State University) was treated
with NdeI and HindIII restriction enzymes while the pET-27b(+) vector (Novagen, Madison, WI) was digested
with NcoI and HindIII and pMAL-c2X (New England Biolabs, Beverly, MA) was digested with EcoRI and HindIII
restriction enzymes. All digests were isolated from agarose gels.
Each of the AAP genes and their respective plasmid digests were ligated using the LigaFast Rapid DNA Ligation
System (Promega, Madison, WI) following Promega's protocol. The ligation products were transformed into
DH5α cells as described above. The plasmids were then isolated and the presence of the DNA insert coding for
AAP was confirmed by DNA sequencing (Biotechnology Center, USU). Four expression systems were obtained in
this manner—pT7-54AAP (pt7-AAP), pET-27b(+)-43AAP (ΔC-AAP), pET-27b(+)-32AAP, and pMAL-c2X-32AAP.
Plasmid pVSNMC (Δsp-AAP) encoding the 52 kDa form of AAP (lacking the first 23 amino acids) [15] was a gift
from Prof. Kiyoshi Hayashi.
The DNA sequence of the AAP insert in the pET-27b(+)-43AAP vector revealed two point mutations: K140P and
P294S. To reverse these point mutations, four oligomers were constructed: P140K: forward—5′-GGC AAT GCT
ACG TTT TGG TTG GAA GTT GTT CTC-3′ and reverse—5′-GAG AAC AAC TTC CAA CCA AAA CGT AGC ATT GCC-3
′; P294S: forward—5′-GCA ACC GGT GAC ACA CCA ACA CCA GGC TGA AGC-3′ and reverse—5′-GCT TCA GCC
TGG TGT TGG TGT GTC ACC GGT TGC-3′. The reaction was carried out using the Quick Change Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). The reaction products were transformed into E. coli XL1-Blue
competent cells (recA1 endA1 gyrA96 thi-1 hsdR17supE44 relA1 lac [F′ proAB lacIqZΔM15 Tn10 (Tetr)]) and
grown on LB–agarose plates with a kanamycin concentration of 50 μg/mL. A single colony from the plate was
grown in 50 mL LB with 50 μg/mL kanamycin. Plasmids were isolated using Qiaprep Spin Miniprep kit (Qiagen,
Valencia, CA). The resulting DNA sequence was identical to the published DNA sequence of AAP [10].
The following bacterial hosts were used for over-expression: BL21(DE3)pLysS cells (F− ompT hsdSB(rB−mB−) gal
dcm (DE3) pLysS (CmR)); AD494(DE3)pLysS cells (Δara− leu7967 ΔlacX74 ΔphoAPvuII phoR ΔmalF3 F′
[lac+(lacIq)pro] trxB::kan (DE3) pLysS, (CmR)) (both strains from Novagen, Madison, WI); and BL21 Star (DE3) (F−
ompT hsdSB (rB−mB−) gal dcm rne131 (DE3)) (Invitrogen, Carlsbad, CA). For each plasmid, the transformation
was carried out according to the manufacturer's instructions. Upon transformation, each plasmid was grown in
25 mL of sterile LB medium with 100 μg/mL ampicillin (pT7 and pMAL-c2X-derived vectors) or 50 μg/mL
kanamycin (pET-27 b(+) vectors). When OD600 values reached 0.6–0.8, 0.85 mL aliquots were removed and
mixed with 0.15 mL glycerol. The stock cultures were then stored in liquid nitrogen until needed.

Starter cultures and cell growth
Colonies from stock cultures were obtained by scraping the surface of the stock culture with a sterile pipette tip
followed by immediate inoculation of sterile LB medium (25 mL). The starter culture was grown in a water bath
at 37 °C until the OD600 was between 0.6 and 0.8. The resulting starter culture was used to inoculate a 5 L

fermentor growth (New Brunswick, Edison, NJ). The bacteria were further grown at 37 °C with aeration until the
OD600 reached 1.2. At this point, the medium was induced with 1.2 g IPTG and grown for an additional 3 h at
37 °C (pMAL-c2X-32AAP). Alternatively, the temperature was lowered to 25 °C before the addition of 1.2 g IPTG
and the bacteria were allowed to grow for 12–16 h. The cells were then harvested by centrifugation in a
Beckman Avanti J-25 centrifuge (8000 rpm, 15 min, 4 °C). The cells were collected and frozen at −20 °C while the
supernatant was collected and stored at 4 °C.

Purification of the MBP–AAP fusion protein
Typically, 2.5–3.0 g of cell paste was resuspended in 10 times their volume of 20 mM Tris buffer (pH 8.0),
200 mM NaCl, and 1 mM EDTA at 4 °C. Cells were lysed by sonication (4 × 1 min) with 1 min intervals with the
tube containing cells kept on ice (Sonicator Cell Disruptor W-375, Heat System-Ultrasonics, Farmingdale, NY).
The debris was separated from the cell extract by centrifugation for 40 min at 18,000 rpm at 4 °C. Clear
supernatant was diluted with twice the volume of the same buffer and applied to a 1.5 × 18 cm amylose column
(New England Biolabs, Beverly, MA) at a flow rate of 0.2 mL/min at 4 °C. The column was subsequently washed
with 12 column volumes of the same buffer to elute any unbound protein. The fusion protein was eluted from
the column using 20 mM Tris buffer (pH 8.0), 200 mM NaCl, 1 mM EDTA, and 10 mM maltose. Fractions
containing protein were pooled and concentrated in an Amicon stirred cell equipped with a YM10 ultrafiltration
membrane (Millipore, Bedford, MA). Protein concentrations were determined using a Bio-Rad assay (Bio-Rad
Laboratories, Hercules, CA). The fusion protein was cleaved by factor Xa at a 50:1 ratio (by weight) at 10–20 °C.

Purification of AAP located in the supernatant
The supernatant, after centrifugation (containing LB and the protein), was saturated with ammonium sulfate.
The precipitate was collected by centrifugation at 10,000 rpm for 45 min at 4 °C. The pellet, containing AAP, was
re-suspended in 30 mL of 10 mM Tricine buffer (pH 8.0) containing 0.1 mM Zn(II). This AAP solution was dialyzed
overnight against 4 L of the same Tricine buffer. The protein solution was then centrifuged at 18,000 rpm for
10 min (4 °C) to remove any insoluble precipitate. The supernatant was concentrated in an Amicon stirred cell to
5–10 mL and NaCl was added to a final concentration of 1 M. The sample was then loaded onto a phenylSepharose column (2.5 × 33 cm) (Amersham Biosciences, Piscataway, NJ) pre-equilibrated with 10 mM Tricine
buffer, pH 8.0, 1 M NaCl, and 0.1 mM ZnSO4 to remove a brown pigment arising from LB medium that binds to
AAP. pt7-AAP and Δsp-AAP (both 54 kDa proteins based on amino acid sequence) were eluted with 10 mM
Tricine buffer, pH 8.0, and 0.1 mM ZnSO4. Active fractions were concentrated to 5 mL and loaded onto a Fast
Flow Q-Sepharose column (5 × 23 cm) (Amersham Biosciences, Piscataway, NJ) that had been equilibrated with
10 mM Tricine buffer, pH 8.0, 0.1 mM ZnSO4. The protein was further separated from the LB-derived pigment by
elution with a 0–1 M NaCl gradient. Active fractions were pooled and concentrated. Removal of any remaining
pigment required a second phenyl-Sepharose chromatography step. Purified AAP used for kinetic experiments
underwent proteinase K and heat treatment at 70 °C.

Purification of periplasmic AAP
Periplasmic AAP was purified by suspending ∼10 g of cell paste in 50–100 mL Tricine buffer (10 mM Tricine, pH
8.0, 20% sucrose, and 0.1 mM Zn(II)) or 50–100 mL Tris buffer (33 mM, pH 8.0, 40% sucrose) with and without
1.5 mM EDTA. The cells were stirred to resuspend the pellet, placed on ice for 10–20 min at 4 °C, and then
centrifuged (8500 rpm, 15 min at 4 °C). The cells were then resuspended in 30–50 mL Tricine that had been
cooled to 4 °C (10 mM Tricine, pH 8.0, 0.1 mM Zn(II)) or 30–50 mL of water (4 °C) containing 1 mM MgCl2 with
less than 0.1 mg DNase I. The sample was shaken vigorously to resuspend the pellet followed by incubation on
ice for 20–30 min. The protein solution was separated from debris by centrifugation (18,000 rpm, 40 min, 4 °C)
and concentrated to 5 mL. The resulting solution was applied to a Fast Flow Q-Sepharose column (5 × 23 cm)
(Amersham Biosciences, Piscataway, NJ) pre-equilibrated with 10 mM Tricine buffer, pH 8.0, 0.1 mM ZnSO4. AAP
was eluted with a 0–1 M NaCl gradient and active fractions were collected and concentrated to 5 mL followed by
loading on an octyl-Sepharose column (3 × 30 cm) (Amersham Biosciences, Piscataway, NJ) that had been pre-

equilibrated with 10 mM Tricine buffer, pH 8.0, 1 M NaCl, and 0.1 mM ZnSO4. AAP was eluted from the octylSepharose column with 10 mM Tricine buffer, pH 8.0, 0.1 mM ZnSO4, concentrated, and sent for Mass Spec
analysis which revealed several impurities in the 7000–12,000 Da range. To further purify this AAP sample, the
protein solution was concentrated in a Centricon with a 30 kDa cut-off membrane (YM30, Amicon) and then
washed with 10 mM Tricine, pH 8.0, 0.1 mM Zn(II).

Purification of proteinase K treated AAP
To process recombinant AAP to the 32 kDa form (equivalent to native enzyme), the crude supernatant
containing the protein after dialysis was treated with proteinase K at 37 °C. The activity of AAP towards l-pNA
was monitored every 5 min. When the activity did not change after two consecutive measurements, the enzyme
solution was heated at 70 °C. Upon concentration in an Amicon stirred cell containing a YM10 membrane to 5–
10 mL, the enzyme was mixed with NaCl to a final concentration of 1 M. The enzyme solution was then applied
to an octyl-Sepharose column (3 × 30 cm) (Amersham Biosciences, Piscataway, NJ) that had been preequilibrated with 10 mM Tricine buffer, pH 8.0, 1 M NaCl, and 0.1 mM ZnSO4. AAP was eluted with 10 mM
Tricine buffer, pH 8.0, containing 0.1 mM ZnSO4. The pooled fractions of AAP were concentrated in an Amicon
stirred cell. To remove any additional pigment associated with the protein, derived from LB broth, a second
purification step was employed that involved applying the AAP sample to a Fast Flow Q-Sepharose column
(Amersham Biosciences, Piscataway, NJ) (3 × 30 cm) pre-equilibrated with 10 mM Tricine buffer, pH 8.0, 0.1 mM
ZnSO4. AAP was eluted with a 0–1 M NaCl gradient. All purification steps were carried out at 4 °C and the purity
of each final AAP sample was confirmed by SDS–PAGE.

Enzymatic assay of AAP
AAP was assayed for catalytic activity using l-pNA as the substrate [12]. In this assay, the hydrolysis of l-pNA was
measured spectrophotometrically by monitoring the formation of p-nitroaniline at 405 nm (ε=10,800 M−1 cm−1)
in a cell with a 1-cm light path. All assays were performed on a Shimadzu UV-3101PC spectrophotometer
equipped with a constant-temperature cell holder and an Isotemp 2013D water bath (Fisher Scientific,
Pittsburgh, PA). All assays were carried out at 25 °C in 10 mM Tricine, pH 8.0, containing 0.1 mM ZnSO4 using
substrate concentrations between 0.2 and 8 Km.

Apo-enzyme preparation
The purified and concentrated 32 kDa form of rAAP (10–20 mg/mL) was incubated with 10–15 mM disodium
EDTA at 4 °C until no activity was observed (usually 1–3 days). To remove EDTA, the protein was dialyzed
extensively against 100 times the volume of chelexed 50 mM Hepes buffer, pH 7.5. The activity of the dialyzed
protein was less than 1% of the activity of the protein reconstituted with two equivalents of Zn(II). All
plasticware used for dialysis and the dialysis tubing itself were presoaked in a disodium-EDTA/bicarbonate
solution to remove all traces of metals and were then extensively washed with 50 mM Hepes buffer, pH 7.5, that
had been run through a Chelex column.

Spectroscopic measurements
Electronic absorption spectra were recorded on a Shimadzu UV-3101PC spectrophotometer. Apo-protein
samples in metal-free 50 mM Hepes buffer, pH 7.5, were degassed prior to incubating with Co(II) (CoCl2:
⩾99.999%, Acros Organics, Geel, Belgium). All electronic absorption spectra were recorded at 25 °C.

Results
Over-expression of the entire ORF of AAP
Over-expression of the entire ORF of AAP in BL21(DE3) cells provided an active enzyme with a molecular weight
of approximately 54 kDa located in the supernatant (pt7-AAP). Expression in BL21(DE3) cells yielded ∼10 mg of
enzyme in the supernatant while ∼3 mg is retained within the cell. However, expression in the BL21Star cell line
yielded approximately 40 and 4 mg of protein in the supernatant and within the cell, respectively. Amino acid
sequence analysis revealed that the over-expressed enzyme found in the supernatant lacked the native signal
sequence and as a result, its molecular weight was 51.6 kDa (Table 1). This form of the enzyme was
thermostable and did not undergo processing. However, upon treatment of the supernatant form of pt7-AAP
with proteinase K and heating to 70 °C for 1–2 h, the 51.6 kDa enzyme was processed to a 32 kDa form of AAP
which has the same molecular weight and N-terminal amino acid sequence as wild-type AAP (Table 1).
Table 1. N-terminal amino acid sequence and molecular weight of each form of AAP based on cellular
localization
Expression system

Location

Aeromonas
proteolytica
(Vibrio
proteolyticus)
pT7-54AAP

Processed extracellular proteina

N-terminal amino acid
sequence
MPPIT

Periplasmc
Extracellular protein
Processed extracellular proteind

—
EDKVW
MPPIT

pET27b(+)-43 AAP

Extracellular (supernatant)

EDKVW

Heat-treated extracellular
protein

ND

30,923 (30%)b
—
51,550 (100%)
32,099 (100%)
64,060 (20%)
40,709 (100%)
39,654 (20%)
8029 (100%)

MPTTL
MPTTL
EDKVW
ASFVM

32,795 (40%)
32,415 (100%)
51,092 (100%)
42,664 (100%)

MPPIT

31,866 (100%)
32,774 (70%)
11,360 (100%)
44,302 (50%)
43,214 (35%)
46,331 (25%)

pVSNMC

Periplasm
Extracellular protein
Proteinase K-treated
extracellular protein
Processed extracellular proteind
Periplasm

ND
ND
MPTTLe
EDKVL and EEHNR

Molecular weight
(Da)
32,148 (100%)b

N-terminal amino acid sequence and molecular weight of each form of AAP based on cellular localization
Molecular weights were obtained by matrix-assisted laser desorption ionization-time of Xight (MALDI-TOF) spectrometric
analysis. The inten- sity of the peak is given in parenthesis.
ND—not determined.
a
Heat treated at 70 °C (native protein).
b
Broad peaks ( 1000 Da).
c
Very low activity detected.

d
e

Treated with proteinase K (37 °C) followed by heat treatment (70 °C).
The only sequence obtained after extensive wash of the periplasmic fraction in a Centricon YM30.

Over-expression of the AAP ORF in E. coli using the pVSNMC plasmid (Δsp-AAP) provided active AAP enzyme in
the growth medium. Transformation into BL21 Star (DE3) cells resulted in a significant increase in expression (up
to 60 mg/L purified enzyme vs. 15 mg/L in BL21(DE3) cells). The molecular weight of the Δsp-AAP enzyme was
found to be 51,092 Da (Table 1), which is slightly lower than the molecular weight deduced from the DNA
sequence (52,026 Da). Amino acid sequencing and mass spectrometry analyses revealed that the signal peptide
is absent so the Δsp-AAP enzyme starts with the same sequence as the N-terminal propeptide of AAP (Table 1).
Therefore, the lower molecular weight indicates that the Δsp-AAP enzyme is truncated at the C-terminus.
To determine the catalytic properties of the recombinant 51 kDa form of AAP, the kinetic parameters Km and kcat
were obtained using l-pNA as the substrate. The supernatant forms of both pt7-AAP and Δsp-AAP exhibited Km
values of 455 and 438 μM, respectively, and kcat values of 464 and 525 min−1, respectively (Table 2).
Interestingly, the observed kinetic parameters for the 51 kDa forms of AAP are significantly different from those
of wild-type AAP (Km =10.6μM and kcat=4280 min−1). Additionally, the 51 kDa enzymes exhibited a time
dependence for substrate cleavage (Fig. 1). Such a behavior is typically observed in inhibition studies with slow
binding inhibitors, where upon prolonged incubation of the enzyme–inhibitor complex, the reaction is initiated
with the addition of a substrate. This results in an increase of the velocity of the reaction due to dilution of the
enzyme–inhibitor complex with the substrate [20].
Table 2. Kinetic parameters for the different forms of rAAP derived from pVSNMC
Km (μM)

kcat (min−1) kcat/Km (min−1 μM−1

51 kDa pt7-AAP (plasmid pT7-54AAP)

455 ± 38

464 ± 14

1.02

51 kDa sp-AAP (pVSNMC plasmid)

438 ± 35

525 ± 18

1.20

43 kDa sp-AAPa (pVSNMC plasmid)
11.3 ± 0.4 3843 ± 44
32 kDa sp-AAPb (pVSNMC plasmid)
11.8 ± 0.4 4050 ± 50
WT AAP (mature from Vibrio proteolyticus) 10.6 ± 0.3c 4280 ± 42
a.
b.
c.

340
360
404

Proteinase K-treated, lacking part of the N-terminal propeptide.
Proteinase K-treated (37°C) and heat treated (70°C).
Typical values of Km found in the literature vary from 10 to 18μM [12], [37].

Fig. 1. Progress curve for the hydrolysis of l-pNA (990 μM) by ΔC-AAP (solid line) and Δsp-AAP (dashed line) at
25 °C in 10 mM Tricine buffer, pH 8.0. Inset: Expanded (0–60 s) region of l-pNA hydrolysis by Δsp-AAP.

Over-expression of a C-terminal truncated form of AAP
A 43 kDa form of AAP encoding the mature protein preceded by its N-terminal propeptide but lacking the Cterminal propeptide (ΔC-AAP) was over-expressed in a pET-27b(+) vector. Approximately 70 mg of pure enzyme
was obtained from a 5 L culture using this expression vector and less than 1 mg of protein was retained within
the cell. The predicted molecular weight of the pET-27 b(+)-43AAP (ΔC-AAP) enzyme is 43,235 Da, however,
enzyme found in the supernatant had a mass of 40,709 Da based on Mass Spec data. N-terminal sequence
analysis revealed that the observed mass difference of ∼2.5 kDa is due to the loss of the first 21 amino acids of
the N-terminal leader sequence of AAP, providing an enzyme with a molecular weight 40,880 Da (Table 1).
Interestingly, Mass Spec analysis of the AAP enzyme retained within the cell revealed a truncated form that lacks
most of the N-terminal propeptide sequence (Table 1).
The catalytic properties of the ΔC-AAP enzyme were also examined and ΔC-AAP exhibited a progress curve
similar to those observed for pt7-AAP and Δsp-AAP (Fig. 1). The initial velocity was two times slower than the
steady-state velocity. Kinetic parameters were obtained from the steady-state velocity at each substrate
concentration by fitting these data to the Michaelis–Menten equation. Based on these fits Km was found to be
142 μM, which is 10 times greater than that of wild-type AAP, however, the observed kcat value was 4346 min−1,
which is identical (within error) to that observed for wild-type AAP (Table 3). Based on X-ray crystallography, the
active site conformation of wild-type AAP does not change upon substrate binding [21], therefore, the Nterminal propeptide sequence must be responsible for the observed changes in kinetic parameters. Based on Xray crystallographic analysis of AAP and with the help from a secondary structure prediction tool2 [21] the first
13 amino acid residues of the N-terminal propeptide are likely disordered, suggesting that they can enter the
active site of AAP and act as an inhibitor (Fig. 2). An estimate of the inhibitory properties of the N-terminal
propeptide was obtained by fitting the experimental data to the Michaelis–Menten equation (1):

V=kcat [E]t [S]/(Km +[S]),

(1)

where V is the velocity, kcat is the reaction rate of the rate-limiting step, kcat[E]t=Vmax is the maximum velocity of
the reaction, [E]t is the total enzyme concentration used in the reaction, [S] is the substrate concentration, and
Km is the Michaelis–Menten constant. Based on the fact that the kcat value obtained for ΔC-AAP is identical
(within error) to the kcat value observed for wild-type AAP, the N-terminal propeptide is likely a competitive
inhibitor that affects only Km. Therefore, Eq. (2), which describes competitive inhibition, resembles Eq. (1) but
includes the inhibition factor, Ki.

V=kcat [E]t [S]/(Km (1+[I]/Ki )+[S]).

(2)

Since kcat and Vmax for ΔC-AAP and wild-type AAP are identical within error, and [S]→∞,V→Vmax :

Km1 =Km (1+[I]/Ki ),

(3)

where Km1 (142 μM) is the Michaelis constant of the enzyme inhibited by the N-terminal propeptide and Km
(11 μM) is the Michaelis constant of wild-type AAP. The Ki value obtained for the N-terminal propetide of ΔCAAP was found to be 0.13 nM. This value is an estimate of the true Ki value and likely represents a high-end
estimate since the propeptide is an integral part of AAP [22], [23], [24].
Table 3. Kinetic parameters of recombinant AAP obtained from the pET27b(+)-43AAP vector
pET27b(+)-43AAP
Extracellular protein

Km (μM)
142 ± 10

kcat (min−1)
4346 ± 101

kcat/Km (min−1 μM−1)
30.5

Heat-treated
extracellular protein
Treated extracellular
proteina
WT AAP (mature from
Vibrio proteolyticus)
a.

16.6 ± 1.2

2211 ± 40

133

10.4 ± 0.4

1519 ± 17

146

10.6 ± 0.3

4280 ± 42

404

Upon proteinase K and heat treatment at 70°C.

Fig. 2. Prediction of the secondary structure of the N-terminal propeptide of AAP (c-random coil; e-extended
strand; and h-alpha helix). This analysis was performed using a web-based program available through PBIL, Lyon,
France at: http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_gw [21]. The first 13 amino acids
(underlined) are largely unfolded and may enter the active site of AAP and inhibit the enzyme.

Over-expression of an N- and C-terminal truncated form of AAP
Over-expression of AAP lacking both the N-terminal and C-terminal propeptide sequences (plasmids pT7-32AAP
and pET27b(+)-32AAP) resulted in the formation of inclusion bodies that could not be solubilized (Fig. 3). As a
result, no enzyme activity was observed using these expression systems. The formation of inactive protein was
hypothesized to be the result of the reducing environment in the cytosol, thus, preventing proper formation of
the single disulfide bond in AAP. To test this hypothesis, E. coli strain AD494(DE3) pLysS was used, which is a
thioredoxin reductase mutant strain, which has been shown to increase disulfide bond formation in the
cytoplasm leading to the proper folding of proteins [25]. However, E. coli strain AD494(DE3) pLysS still provided
only insoluble inclusion bodies of AAP.

Fig. 3. SDS–PAGE for the over-expression of the 32 kDa form of AAP using pT7-32AAP expression vector (lanes:
1—protein marker; 2—cells before induction; 3—cells 3 h post-induction with IPTG; 4—protein marker; and 5—
cell debris upon cell breaking).

To produce a soluble, active form of the 32 kDa AAP, a pMAL-c2X vector was used which contains a strong Ptac
promoter [26], [27], [28]. This particular vector lacks the malE signal sequence and thus, the fusion protein is
retained in the cytoplasm. In addition, a factor Xa cleavage site was designed into the vector directly preceding
the cloning site of the AAP gene, to cleave the AAP enzyme from maltose-binding protein (MBP). The MBP–AAP
fusion protein was over-expressed in both BL21 and AD494 cells and purified using an amylose column that
selectively binds MBP. The molecular weight of the fusion protein was determined from SDS–PAGE to be
∼70 kDa, which is in excellent agreement with the combined molecular weight of MBP and AAP (72 kDa).
Cleavage of the fusion protein resulted in the disappearance of the 70 kDa band and the concomitant
appearance of two new bands at 30 and 40 kDa, which correspond to AAP and MBP, respectively (Fig. 4). The
band at approximately 30 kDa was less intense than the band corresponding to the MBP, suggesting that AAP
was further processed by factor Xa. In addition, several bands were also observed in the SDS gel below 30 kDa
consistent with additional processing of AAP by factor Xa.

Fig. 4. SDS–PAGE showing the cleavage of the MBP–AAP fusion protein by factor Xa (lanes: 1—protein marker,
10 kDa spacing; 2—maltose-binding protein–AAP fusion protein; 3—digestion with factor Xa (2 h, 15 °C); 4—
digestion with factor Xa (4 h); 5—digestion with factor Xa (8 h); 6—digestion with factor Xa (25 h); and 7—native
AAP). Native 32 kDa AAP is often processed to a 28–29 kDa protein [38], [39].

Production of a soluble, active 32 kDa form of AAP
The recombinant 51 kDa form of AAP (pt7-AAP) was used to produce a heat stable, fully processed form of AAP
that is identical to wild-type AAP. Since wild-type AAP has been suggested to be processed by a neutral
protease, we treated pt7-AAP with proteinase K at 37 °C. Treatment of pt7-AAP with proteinase K was
monitored by measuring AAP activity towards l-pNA, which revealed a continuous increase in initial velocity that
eventually lapsed providing a straight line. These data suggest that AAP is no longer inhibited by its N-terminal
propeptide, suggesting that proteinase K treatment provides a partially processed AAP enzyme with a molecular
weight of 43 Da. N-terminal amino acid sequencing and Mass Spec data indicate that proteinase K treatment
does in fact remove part of the N-terminal propeptide 81 amino acids (Table 1). The resulting 43 kDa enzyme
exhibited Km and kcat values that are nearly identical to those of native AAP (Km =10.8μM vs. 10.6 μM; kcat 3800
vs. 4280 min−1 for processed pt7-AAP and WT AAP, respectively). Further processing did not occur under these
conditions, even upon prolonged treatment of AAP with proteinase K.
Increasing the temperature of the N-terminal processed 43 kDa AAP enzyme to 70 °C in the presence of
proteinase K resulted in additional processing of AAP. After heat treatment, a 32 kDa AAP enzyme was obtained
that contained identical N- and C-terminal amino acid sequences to wild-type AAP (Table 1). Addition of a
proteinase K inhibitor (PMSF) prior to heat treatment at 70 °C did not result in the formation of a 32 kDa form of
AAP, suggesting that the 43 kDa form of AAP is not capable of auto-processing. The fully processed overexpressed 32 kDa form of AAP exhibited identical kinetic parameters to those of wild-type AAP (Table 2).
Interestingly, processing of the ΔC-AAP enzyme with proteinase K and heat treatment at 70 °C provided an

enzyme with an identical Km value as wild-type AAP (10.4 μM) but was much less active 1519 vs. 4346 min−1 for
processed ΔC-AAP vs. wild-type, respectively (Table 3).

Spectroscopic characterization of the recombinant 32 kDa form of AAP
Since the proteinase K and heat treated 51 kDa form of AAP (pt7-AAP) displayed identical kinetic parameters
and molecular weight as wild-type AAP (Table 1, Table 3), the structural integrity of the dinuclear Zn(II) active
site was characterized by UV–Vis spectrometry. Reconstitution of the apo-32 kDa form of AAP (rAAP) with one
and two equivalents of Co(II), provided electronic absorption spectra with extinction coefficients of ε525=56 and
109 M−1 cm−1, respectively. These data are in good agreement with the molar absorptivities and λmax values
observed for wild-type AAP in the presence of one and two equivalents of Co(II) (i.e., ε525=45 and 97 M−1 cm−1).
UV–Vis titration of Co(II) into rAAP provided the number of divalent metal ions bound to the enzyme. Upon the
addition of Co(II) to rAAP, the molar absorptivity at 525 nm increased gradually until two equivalents of Co(II)
had been added. No significant change was observed upon the addition of excess Co(II), suggesting that rAAP
binds only two divalent metal ions in the active site, identical to wild-type AAP.

Discussion
The gene encoding the leucine aminopeptidase from A. proteolytica (V. proteolyticus) (AAP) provides an enzyme
with a molecular weight of 54 kDa. However, the “as-purified” wild-type enzyme from A. proteolytica (V.
proteolyticus) is only 32 kDa. Very little is known about the nature of the cleavage process leading to mature
enzyme, but expression of proproteins is a common feature among many proteases [23], [29], [30], [31], [32],
[33]. Classic examples of protein activation through removal of a propeptide are the enzymes of the digestive
tract expressed as inactive zymogens. In addition, several proteases, including metallo-enzymes such as
subtisilin, thermolysin, carboxypeptidase A, and Npr from Bacillus brevis undergo processing upon secretion
[23], [29], [30], [31], [32], [33]. Therefore, the development of a fundamental knowledge of maturation
processes involving N-terminal leader sequences and N- or C-propeptides is an important outstanding problem.
The open-reading frame (ORF) of AAP contains four distinct domains: (i) a leader peptide, (ii) an N-terminal
propeptide, (iii) the mature enzyme, and (iv) a C-terminal peptide (Scheme 1). Leader peptides typically direct a
protein to a specific compartment within the cell, which in the case of AAP results in its transportation across
the periplasmic space and the outer membrane so that it is secreted extracellularly. The AAP signal peptide
appears to be very efficiently recognized by the A. proteolytica bacterial transport system since little to no AAP
activity is found within the periplasmic space of the bacterium. Comparison of hydrophobicity plots of several
signal sequences such as PelB, MalE, and OmpA suggests that the first 21 amino acids of the ORF of AAP
constitute the signal peptide of AAP (Fig. 5). These data are in contrast to those reported by Guenet et al. [11]
where they suggested that amino acids 73–106 constituted the signal peptide of AAP. Based on the
hydrophobicity plots, the AAP signal peptide bears the closest resemblance to OmpA and shows distinct
hydrophobicity, as opposed to the amino acids in positions 76–103 (Fig. 5, Fig. 6). This similarity to other signal
peptides was hypothesized to lead to effective secretion of AAP from E. coli using the native AAP signal peptide.
Secretion of AAP into the culture medium was observed with less than 10% of the total amount of AAP
produced retained in the cell. A similar result was obtained when an E. coli leader sequence, PelB, replaced the
native sequence in AAP. The observed hydrophobicity plots are also consistent with the prediction made by Van
Heeke et al. [10] and are in excellent agreement with the (−3, −1) rule for signal sequences [34]. Conversely, the
lack of initial 21 amino acids results in the accumulation of inactive protein in the bacterial cell (Fig. 3).

Scheme 1. Proposed processing of AAP during secretion and purification. The four different domains
constituting AAP are: (1) the signal peptide (21 amino acids), (2) an N-terminal propeptide (89 amino acids), (3)
the mature protein (291 amino acids), and (4) a C-terminal propeptide (107 amino acids). Upon secretion of AAP
a thermostable, 32 kDa enzyme is formed through a 43 kDa protein intermediate.

Fig. 5. Hydrophobicity plot of the propeptide sequence of AAP.

Fig. 6. Comparison of the hydrophobicity of known signal peptides.
The N-terminal propeptide was previously proposed to be required for proper folding of AAP [15]; however, its
presence alone does not guarantee proper folding of the enzyme. If the signal peptide does not precede the Nterminal propeptide, AAP is not properly folded and is found in the insoluble cellular fraction [15]. The use of an
E. coli thioredoxin reductase mutant strain, AD494, which in some cases helps in the formation of disulfide
bonds in the cytoplasm [25], does not result in the formation of properly folded protein. There are six cysteines
in the ORF of AAP—two in the N-terminal propeptide, C-terminal propeptide, and mature protein; the last two
are not likely to be involved in protein folding as lack of the C-terminal propeptide results in the formation of
active protein. These data suggest that proper protein folding may occur only in the periplasmic space or outside
the cell where the environment is less reductive. Since thioredoxin usually acts on exposed disulfide bonds, the
formation of the only disulfide bond within mature AAP (Cys223 and Cys227) may be critical for proper folding
[35].
Several metalloenzymes have been shown to be inhibited by their respective N-terminal propeptides [23], [29],
[30], [31], [32], [33]. Many of these propeptides are competitive inhibitors spanning a broad range of inhibition
constants (0.1–2000 nM) [23], [36]. The N-terminal propeptide of AAP appears to be a competitive inhibitor of
AAP with an approximate Ki value of 0.13 nM. This Ki value is very similar to that observed for N-terminal
propetide inhibition of another metalloenzyme, carboxypeptidase A (Ki=2 nM) [24]. Upon cleavage of the Nterminal propeptide by proteinase K (ΔC-AAP), the inhibitory properties of AAP's propeptide are eliminated
since the observed Km value decreases from 142 to 11 μM, which is identical to wild-type AAP. Similarly, the
proteinase K truncated form of the pVSNMC-encoded AAP enzyme exhibits a Km value of 11 μM, a value that is
also significantly lower than that for the unprocessed enzyme (438 μM) (Table 2, Table 3). In the latter case,
upon proteinase K treatment the catalytic efficiency increases four times while a twofold decrease in kcat is
observed for ΔC-AAP. These data suggest that the C- and N-terminal propeptides of AAP interact with one
another and that they likely inhibit the AAP enzyme in a cooperative fashion. Moreover, these data suggest that
the C-terminal propeptide is involved in stabilizing AAP, particularly during the heat treatment to 70 °C since no
decrease in activity is observed for AAP containing the C-terminal propeptide upon proteinase K and heat
treatment. N- and C-terminal interaction is also consistent with the observed Km values for the 51 kDa form of
AAP (438 μM) vs. the C-terminal truncated form of AAP (142 μM). These data suggest that proteinase K closely
resembles the native endopeptidase involved in processing AAP, since rAAP exhibits an identical molecular

weight, shares the same N-terminal sequence, exhibits identical kinetic properties, and is spectroscopically
indistinguishable from wild-type AAP.
Based on these data, a mechanism for processing the 51 kDa form of AAP to its wild-type 32 kDa form can be
proposed (Scheme 1). The ORF encodes a protein of a 54 kDa molecular weight. The protein is directed to the
periplasm where it crosses the outer membrane; during this process the signal peptide is separated from the
rest of the protein by a signal peptidase leaving a 51–52 kDa protein. This sequence of events is supported by
the presence of an SDS–PAGE band for excreted AAP at approximately 50 kDa, corresponding to unprocessed
AAP. In the following step, the N-terminal propeptide is removed by an endopeptidase. The current form of AAP
still retains its C-terminal propeptide and the molecular weight is ∼43 kDa but during heat treatment, the Cterminal propeptide is removed. Since inhibition of proteinase K with PMSF directly preceding the heattreatment step inhibits the truncation at C-terminus, it is likely that an endopeptidase catalyzes this step. The
final product is a 32 kDa, thermostable enzyme that is resistant to proteolysis by the endopeptidase responsible
for AAP processing. The nature of this endopeptidase is unknown at this time, but a neutral protease that is coproduced with AAP in A. proteolytica (V. proteolyticus), is a likely candidate.
In conclusion, we have successfully over-expressed the leucine aminopeptidase from A. proteolytica (V.
proteolyticus) in E. coli using its native signal peptide. The successful extracellular excretion of AAP from E. coli
using its native signal peptide provides an additional signal peptide for the development of E. coli expression
systems for proteins that do not fold properly in the cytosol. Characterization of the proteinase K-processed AAP
enzymes allowed the first detailed model for the maturation of wild-type AAP to be proposed. A cooperative
inhibitory interaction between the N- and C-terminal propeptides of AAP was observed and the kinetic
characterization of the various forms of AAP revealed that the N-terminal propeptide is a strong inhibitor of AAP
activity (Ki∼0.13 nM). These data provide the basis for the design of a new class of leucine aminopeptidase
inhibitors. In addition, a fully processed recombinant form of AAP was characterized by kinetic and
spectroscopic methods and this enzyme was shown to be identical to the “as-purified” wild-type AAP enzymes.
Therefore, the ease of purification and processing of rAAP along with the fact that large quantities can be
obtained now allow new detailed mechanistic studies to be performed on AAP through site-directed
mutagenesis.
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Abbreviations used: AAP, mature (32kDa) leucine aminopeptidase from Aeromonas proteolytica (Vibrio
proteolyticus); rAAP, recombinant leucine aminopeptidase; pt7-AAP, recombinant leucine aminopeptidase overexpressed using pT7 vector (containing all domains of native AAP); Δsp-AAP, recombinant leucine
aminopeptidase from pVSNMC expression vector (lacking the native leader sequence); ΔC-AAP, recombinant
leucine aminopeptidase from pET27b(+)-43AAP expression system (lacking the C-terminal propeptide
sequence); IPTG, isopropyl-β-d-thiogalactopyranoside; l-pNA, l-leucine-p-nitroanilide; Tricine, (Ntris[hydroxymethyl])methylglycine; malE, maltose-binding protein gene from Escherichia coli; MBP, maltosebinding protein; MHC-I, major histocompatibility complex-I; OmpA, outer membrane protein from E. coli; PelB,
pectate lyase from E. coli; PMSF, phenylmethanesulfonyl fluoride; SDS–PAGE, sodium dodecyl sulfate–
polyacrylamide gel electrophoresis; TOF-MS, time of flight mass spectroscopy; WT, wild-type. Numbers
1

preceding AAP, Δsp-AAP, and ΔC-AAP denote molecular weight of the respective form of the leucine
aminopeptidase.
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